Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program
Circulation: Genomic and Precision Medicine · 2025
DOI: 10.1161/circgen.124.005113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025. Verfasst von Naman S Shetty und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (N.S.S.). Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: This study aimed to evaluate the prevalence of pathogenic/likely pathogenic cardiomyopathy variant carriers in a multiancestry US population and examine the risk of adverse clinical outcomes. METHODS: This retrospective cohort study included multiancestry US adults aged ≥18 years with sequencing data from the All of Us Research Program. Pathogenic/likely pathogenic variants in cardiomyopathy genes were identified using the ClinVar database. The primary outcome was heart failure. Secondary outcomes included cardiomyopathy and arrhythmia. Outcomes were identified from electronic health records. Interval-censored Cox models, taking age on the timescale, were used to assess the risk of outcomes in pathogenic/likely pathogenic variant carriers with noncarriers as the reference group. RESULTS: Among 167 435 individuals (median age, 55.2 [39.5–66.3] years; 61.7% female; 40.7% non-European ancestry) included, the prevalence of pathogenic/likely pathogenic cardiomyopathy variant carriers was 0.7% in the overall population and 0.8%, 0.8%, 0.5%, and 1.2% among European, African, East Asian, and South Asian ancestry individuals, respectively. Over their lifetime, there were 12 867 heart failure events (205 in carriers and 12 662 in noncarriers), with an incidence rate of 3.05 (95% CI, 2.66–3.49) per 1000 person-years in carriers and 1.37 (95% CI, 1.35–1.40) in noncarriers (adjusted hazard ratio, 2.30 [95% CI, 2.04–2.60]). Cardiomyopathy occurred in 5164 (161 in carriers and 5003 in noncarriers), with an incidence rate of 2.38 (95% CI, 2.04–2.78) per 1000 person-years among carriers and 0.54 (95% CI, 0.53–0.56) in noncarriers (adjusted hazard ratio, 4.31 [95% CI, 3.73–4.97]). There were 19 405 arrhythmia events (263 in carriers and 19 142 in noncarriers), with an incidence rate of 3.93 (95% CI, 3.48–4.44) per 1000 person-years among carriers and 2.09 (95% CI, 2.06–2.12) in noncarriers (adjusted hazard ratio, 2.12 [95% CI, 1.78–2.53]). CONCLUSIONS: Pathogenic/likely pathogenic cardiomyopathy variant carriers have an increased risk of heart failure, cardiomyopathy, and arrhythmias. Despite the modest overall prevalence, the associated risks suggest potential benefits of targeted genetic screening for early detection and management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston (N.S.S.).
- Harvard Medical School, Boston, MA (N.S.S.).
- Division of Cardiovascular Disease (A.P., M.G., N.P., N.V., G.A., P.A.), University of Alabama at Birmingham.
- The Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine and Science for Life Laboratory, University of Gothenburg, Sweden (J.G.S.).
- Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden (J.G.S.).
- Department of Cardiology, Clinical Sciences, Lund University & Skåne University Hospital (J.G.S.), Lund, Sweden.
ORCID-Profile: Naman S Shetty, Akhil Pampana, Mokshad Gaonkar, Nehal Vekariya, J Gustav Smith, Rajat Kalra, C Anwar A Chahal, Christopher Semsarian, Peng Li, Pankaj Arora
Zitieren
APA
Shetty, N. S., Pampana, A., Gaonkar, M., Patel, N., Vekariya, N., Smith, J. G., Kalra, R., Chahal, C. A. A., Semsarian, C., Li, P., Arora, G., & Arora, P. (2025). Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.124.005113
Vancouver
Shetty NS, Pampana A, Gaonkar M, Patel N, Vekariya N, Smith JG, et al. Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program. Circulation: Genomic and Precision Medicine. 2025. doi:10.1161/circgen.124.005113
BibTeX
@article{Shetty2025,
author = {Shetty, Naman S and Pampana, Akhil and Gaonkar, Mokshad and Patel, Nirav and Vekariya, Nehal and Smith, J Gustav and Kalra, Rajat and Chahal, C Anwar A and Semsarian, Christopher and Li, Peng and Arora, Garima and Arora, Pankaj},
title = {Association of Pathogenic/Likely Pathogenic Genetic Variants for Cardiomyopathies With Clinical Outcomes: A Multiancestry Analysis in the All of Us Research Program},
journal = {Circulation: Genomic and Precision Medicine},
year = {2025},
doi = {10.1161/circgen.124.005113}
}
EUVIMED